Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Cognitive Impairment in ALS: Screening Tools, Experiences and Prognosis

NCT03578796 is registered in ClinicalTrials.gov with Haukeland University Hospital as lead sponsor.

NCT NCT03578796
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03578796 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Cognitive Impairment in ALS: Screening Tools, Experiences and Prognosis
Lead sponsor
Haukeland University Hospital
Phase
Observational
Overall status
Completed
Start date
May 1, 2017
Completion date
October 5, 2026
Enrollment
31 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

amyotrophic lateral sclerosis, cognitive impairment